Retatrutide Dosage Calculator: mg, Bac Water & Exact Syringe Units

Reconstituting a retatrutide vial comes down to one number: how many units do you draw on the syringe? This calculator gives you that in one step. Enter how many milligrams are in your vial, how much bacteriostatic water you're adding, and your target dose, and it returns the exact insulin-syringe mark, the concentration you've made, and how many doses the vial holds.

Retatrutide carries an extra wrinkle: it comes in high-milligram vials (often up to 50 mg), so it's easy to mix a vial so concentrated — or pick a dose so large — that a single draw won't fit in one insulin syringe. The calculator flags that overflow before you find out at the vial. Below the tool we walk through the math, show where the trial-studied doses land, and, because we run a tracking app, show what real retatrutide users actually mix. Because retatrutide is investigational, every dose here is framed as studied in trials, never as a recommendation. For how it stacks up against the rest of the field, see our best peptides for weight loss guide.

Key Takeaways

• Two-step math: concentration = vial mg ÷ bac water mL, then units = (dose mg ÷ concentration) × 100 on a U-100 syringe.
• Anchor example: a 20 mg vial + 2 mL of bacteriostatic water = 10 mg/mL; a 4 mg dose = 0.4 mL = the 40-unit mark, and the vial gives 5 doses.
• Watch for overflow. Retatrutide's high-mg vials can push a dose past 100 units (more than one syringe). Our usage data shows a wide spread with a real "100+" tail — the calculator warns you and the fix is more water or a split draw.
• More water = a more diluted vial = a larger number of units for the same milligram dose. The amount of retatrutide never changes with the water.
• Doses are trial figures, not advice. Retatrutide has been studied at 1, 4, 8, and 12 mg weekly in Phase 2 — shown for context only.
• Investigational, not approved. There is no FDA label and no validated shelf life; treat every number with extra caution.

How do you calculate a retatrutide dose?

Retatrutide reconstitution is two steps: work out the vial's concentration, then convert your milligram dose into a volume you can read on the syringe. The units you draw are just that volume on the insulin scale.

In plain arithmetic:

1. Concentration (mg/mL) = vial mg ÷ bac water mL. A 20 mg vial in 2 mL is 20 ÷ 2 = 10 mg/mL.
2. Volume (mL) = dose mg ÷ concentration. A 4 mg dose at 10 mg/mL is 4 ÷ 10 = 0.4 mL.
3. Units = volume × 100 on a U-100 syringe (100 units = 1 mL). So 0.4 mL = 40 units.

Collapsed into the single formula the calculator runs:

units = (dose mg ÷ (vial mg ÷ bac water mL)) × 100 = dose mg × bac water mL ÷ vial mg × 100

Sanity-check our example: 4 × 2 ÷ 20 × 100 = 40 units. For doses per vial, divide the vial's milligrams by your dose: 20 mg ÷ 4 mg = 5 doses.

Our take: Retatrutide's high-mg vials make the overflow trap easy to fall into. Reconstitute a 50 mg vial in just 1 mL (50 mg/mL) and an 8 mg dose is 0.16 mL — fine. But mix that same vial in too little water for a larger dose and you can blow past the 100-unit mark, meaning the dose won't fit in one syringe. Always run your real numbers, and watch for the overflow flag.

How much bacteriostatic water should you add to retatrutide?

Pick the water volume that lands your dose on a readable mark and keeps it under one syringe — with retatrutide's high-mg vials, the overflow ceiling is the constraint that matters most. Too little water on a strong vial pushes big doses past 100 units.

The trade-off is the usual one, with retatrutide's twist. Less water concentrates the vial (smaller unit draws, but a large dose can still overflow if the vial is strong); more water dilutes it (larger, easier-to-read draws). On a 20 mg vial in 2 mL (10 mg/mL), a 4 mg dose is a tidy 40 units and even a 10 mg dose is 100 units — right at the ceiling. Go to a 50 mg vial in 2 mL (25 mg/mL) and the same doses read much smaller, but a 12 mg dose is still under one syringe only because of that dilution.

Because ProtocolPlus tracks reconstitutions, we can show the vial-strength × water-volume combinations real retatrutide users log — the ratios the crowd has settled on.

The pattern: 2 mL is the dominant water choice, and the 20-30 mg vials at 2 mL are the most-logged setups (10-15 mg/mL). That band keeps the trial-studied doses on a readable syringe without overflowing — which is exactly the balance the next sections are about.

A worked walkthrough: choosing water to avoid overflow

Say you have a 30 mg vial and your intended dose is 8 mg. Run the candidate water volumes and watch whether the dose fits one syringe:

• 3 mL → 10 mg/mL. 8 mg = 80 units. Fits, but a 12 mg dose later would be 120 units (overflow).
• 2 mL → 15 mg/mL. 8 mg = 53 units, and 12 mg = 80 units. Everything stays under the ceiling — the clean choice.
• 1 mL → 30 mg/mL. 8 mg = 27 units. Compact and overflow-proof, but the small early doses get harder to read.

The 2 mL option wins because it keeps the whole intended range under 100 units while still reading comfortably — which is the logic behind retatrutide's 2 mL clustering. With this compound, "choose your water for the destination dose" specifically means "choose it so the largest dose you'll take still fits one syringe."

Switching vials mid-course: always recalculate

Opening a new vial of a different strength changes the concentration, so the same dose draws to a different unit mark. Move from a 20 mg vial to a 50 mg vial and even at the same 2 mL the concentration jumps from 10 to 25 mg/mL — an 8 mg dose that was 80 units becomes 32 units. Never carry a unit number across vials; re-run the calculator every time the vial strength or water volume changes.

How do you read retatrutide units on an insulin syringe?

On a U-100 insulin syringe, 100 units = 1 mL, so a unit is a hundredth of a millilitre — the calculator converts your milligram dose into that unit mark. The "units" you read are a measure of volume, not of how much retatrutide you're taking.

Three calibrations exist, and the calculator supports all three:

Always confirm which syringe you're holding before trusting a units figure — and keep an eye on that 100-unit ceiling, which retatrutide reaches more easily than lower-dose peptides.

The overflow problem: retatrutide's signature pitfall

Because retatrutide is dosed in whole milligrams from high-strength vials, a draw can exceed 100 units — more than one standard insulin syringe holds — if the vial is too dilute for the dose. Spotting and fixing that is the most important practical point on this page.

A draw over 100 units doesn't fit in one U-100 syringe (100 units = 1 mL). It happens when a large dose meets a low concentration: a 12 mg dose on a 10 mg/mL vial is 1.2 mL, or 120 units — it won't fit. Across our tracked retatrutide reconstitutions the draws spread widely, with a real "100+" tail that lower-dose peptides simply don't have.

There are two clean fixes, and the calculator flags when you need them:

• Use less bacteriostatic water (a stronger vial) so the same dose occupies less volume and reads under 100 units. A 12 mg dose is 120 units at 10 mg/mL but only 48 units at 25 mg/mL.
• Split the dose across two draws if a single draw still exceeds the syringe.

The median draw sits near 60 units, but the spread is wide and the "100+" overflow bin is real — which is why the overflow flag matters more for retatrutide than for any other GLP-1 on the menu.

Where do the trial-studied retatrutide doses land on the syringe?

The doses studied in retatrutide trials — 1, 4, 8, and 12 mg weekly in Phase 2 — translate to very different unit marks depending on your concentration, and the high end overflows a single syringe on dilute vials. These are trial figures shown for context, not a dosing schedule.

For reference, the Phase 2 obesity trial studied retatrutide at 1, 4, 8, and 12 mg once weekly, with mean weight loss up to about 24% at 48 weeks at the highest dose (The New England Journal of Medicine, 2023, "Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial", retrieved 2026-06-15). Those values are what people enter into a calculator; with a vial you must convert each to units yourself.

Our take: Notice the 12 mg row: on a 10 mg/mL vial it's 120 units and won't fit one syringe, but on a 25 mg/mL vial it's a comfortable 48 units. That's the overflow problem in one line — and the reason a calculator that flags overflow beats a static chart that lets you walk into it. For the trial program and results, see our full retatrutide guide; for the general unit math behind any peptide, the peptide dosage calculator.

How many retatrutide doses are in a vial, and what does each cost?

Doses per vial is vial milligrams ÷ your dose — and dividing the vial price by that gives a true cost per dose. It's the number that tells you what a vial is really worth.

A 20 mg vial at a 4 mg dose yields 5 doses; a 50 mg vial at 8 mg gives 6. Across our tracked retatrutide vials the median works out to roughly 3 doses per completed vial at about $83 per dose, reflecting retatrutide's higher per-milligram cost as a newer compound. Cost per dose is the figure to compare across products, not the sticker price.

Retatrutide reconstitution chart: units by vial size

Reconstituted with the common 2 mL of bacteriostatic water, this chart shows the concentration each vial makes and the U-100 units for the trial-studied doses. A dash means the draw exceeds one 100-unit syringe and needs a stronger vial or a split draw. For any other water volume, use the calculator.

Read the chart and the overflow constraint is plain: low-strength vials (10-15 mg) can't carry the higher trial doses on one syringe at 2 mL, while a 50 mg vial keeps the entire 1-12 mg range comfortably under the ceiling. This is the reason our usage data leans toward stronger vials or less water as the intended dose climbs.

mg, mcg, units, and mL: keeping the four numbers straight

Milligrams measure the retatrutide; millilitres and units measure the liquid you draw. Reconstitution is the bridge between them. Retatrutide lives in the milligram world (1-12 mg studied), so micrograms rarely come up, but it's worth knowing 1 mg = 1,000 mcg if you cross-reference a microgram-dosed peptide.

Here is the 4 mg example expressed four ways on a 10 mg/mL vial, one quantity wearing four labels:

Why concentration is the number that actually matters

Concentration (mg/mL) is the hinge of every retatrutide calculation — and for retatrutide it's also what decides whether a dose fits in one syringe. It connects the milligrams in the vial to the units on the syringe.

Concentration is an exchange rate between milligrams of retatrutide and millilitres of liquid. A 10 mg/mL vial trades every 1 mL for 10 mg; your dose occupies a volume set by that rate, and the syringe scale turns it into a unit mark. Make the vial stronger (less water) and the same dose occupies less volume — fewer units, and crucially, more headroom under the 100-unit ceiling. That's why, uniquely for high-dose retatrutide, concentration choice is partly an overflow-avoidance choice.

It's also why you can never compare unit numbers across reconstitutions. "Draw 40 units" means 4 mg on a 10 mg/mL vial but 10 mg on a 25 mg/mL vial — a 2.5× difference. Every unit instruction online is valid only for that exact vial and water volume.

What "investigational" means for retatrutide dosing

Retatrutide has no FDA label, no approved dose, and no validated shelf life — so every figure on this page, including the trial doses, is educational context, not guidance. This matters more for retatrutide than for approved GLP-1s.

Retatrutide (LY3437943) is a triple GIP, GLP-1, and glucagon receptor agonist that remains investigational and in Phase 3 trials as of 2026, legally available only through Eli Lilly's clinical program (Eli Lilly, 2026, "Retatrutide Phase 3 topline results", retrieved 2026-06-15). Because there's no approved product, there's no manufacturer-validated reconstitution instruction, no official in-use stability window, and no dosing label — which is precisely why the dose values here are framed as amounts studied in trials and the calculator is positioned strictly as arithmetic. Treat the absence of an approved standard as a reason for extra caution, not a gap to fill with a number from a forum.

How to reconstitute retatrutide, step by step

Add the bacteriostatic water slowly down the vial wall, swirl gently until clear, and never shake. The peptide is delicate, and rough mixing degrades it before your first dose.

1. Calculate first. Use the tool above to set your water volume and target unit mark, and check for the overflow flag.
2. Room temperature, then swab both stoppers with a fresh alcohol swab.
3. Draw your measured water into a reconstitution syringe.
4. Add slowly down the wall of the retatrutide vial, onto the glass rather than the powder.
5. Swirl, don't shake until the solution is completely clear.
6. Inspect. Clear and particle-free, or don't use it.
7. Label and refrigerate at 2-8 °C, then dose at the unit mark the calculator gave you.

Reconstitution troubleshooting

• The powder won't fully dissolve. Give it a few minutes and keep swirling gently; warmth from your hands helps. A vial that stays cloudy or shows particles shouldn't be used.
• Foam or a hard vacuum pull. Some vials are under vacuum and suck the water in fast, foaming it; vent briefly with an empty needle or add the water slowly down the wall.
• A draw over 100 units. Not a mixing error — your concentration is too low for the dose. Re-mix a fresh vial with less water, or split the draw.

Common retatrutide dose conversions

The trial-studied doses at the common 2 mL mix, so you can sanity-check the tool (context only, not advice):

• 1 mg retatrutide in a 20 mg vial + 2 mL (10 mg/mL) = 10 units.
• 2 mg retatrutide in a 20 mg vial + 2 mL (10 mg/mL) = 20 units.
• 4 mg retatrutide in a 20 mg vial + 2 mL (10 mg/mL) = 40 units.
• 8 mg retatrutide in a 30 mg vial + 2 mL (15 mg/mL) = 53 units.
• 12 mg retatrutide in a 50 mg vial + 2 mL (25 mg/mL) = 48 units.

Common retatrutide reconstitution mistakes

• Walking into an overflow. A big dose on a dilute vial exceeds one syringe — use a stronger vial or split the draw, and heed the flag.
• Reading "units" as milligrams. Units are a volume; always convert through the calculator.
• Copying someone else's unit count. Valid only for that person's exact concentration.
• Adding water too fast, which foams and can denature the peptide — go slow down the wall.
• Wrong syringe scale (U-40 vs U-100), and not labeling the reconstitution date.

Retatrutide vial sizes and supplies

Retatrutide vials commonly come in 10, 15, 20, 30, and 50 mg — and because of the overflow issue, the stronger vials are often the more practical choice for higher intended doses. Pick the size that keeps your target dose under one syringe on a readable mark.

• 10-15 mg — fine for low doses; can't carry the higher trial doses on one syringe at 2 mL.
• 20-30 mg — the most-logged sizes in our data; a good balance for the mid range.
• 50 mg — keeps the whole 1-12 mg range under the ceiling, at the cost of small early-dose draws.

A quick supplies checklist: the lyophilized retatrutide vial, bacteriostatic water (sterile water with 0.9% benzyl alcohol) as the diluent, a reconstitution syringe (1-3 mL), a U-100 insulin syringe, alcohol swabs, and a marker for the date. Use bacteriostatic — not preservative-free or non-injectable — water for a multi-dose vial.

How long does reconstituted retatrutide last?

Once mixed, retatrutide is far less stable than the dry powder, and because it's investigational there is no validated shelf life at all — the common ~28-day refrigerated convention is a usage habit, not data. Treat appearance as the real guide.

Peptides in solution degrade through hydrolysis, deamidation, oxidation, and aggregation, sped up by heat, light, and agitation, so a mixed vial belongs in the refrigerator at 2-8 °C, kept dark, and never frozen. Discard any vial that turns cloudy, changes color, or shows particles, regardless of the calendar. For the deeper science, see our retatrutide storage and stability guide.

How precise does your retatrutide draw need to be?

The draw should be close enough that rounding to the nearest readable unit mark doesn't meaningfully change your dose — which, with retatrutide's whole-milligram trial doses, is usually easy as long as you're not on an over-concentrated vial. A unit or two of error is trivial at a 40-unit draw.

Syringes are marked in whole units, so some rounding is unavoidable; what it costs depends on concentration. On a 10 mg/mL vial, one U-100 unit is 0.1 mg of retatrutide, so rounding a 40-unit draw by a unit shifts the dose by 0.1 mg — negligible against a 4 mg dose. On a very concentrated 25 mg/mL vial, one unit is 0.25 mg and small draws get jumpier. The practical guidance is the same as the overflow point in reverse: don't over-concentrate a vial whose doses are already small, and don't over-dilute one whose doses are large. The 10-15 mg/mL band our users favor keeps the trial doses on forgiving, mid-syringe marks.

Retatrutide vs tirzepatide: why the numbers differ

Retatrutide is dosed in a similar milligram range to tirzepatide but is a different molecule (a triple agonist), and it tends to come in higher-strength vials — which is why the overflow problem is more of a retatrutide issue. The reconstitution math is identical; only the vial strengths and intended doses differ. If you use both, keep their calculators and vials straight, and don't assume a unit count from one transfers to the other. For a full molecular and outcomes comparison, see our retatrutide vs tirzepatide comparison.

Frequently asked questions

Sources

Factual claims (trial doses, mechanism, investigational status) are sourced below. Dose values reflect amounts studied in trials, not recommendations. ProtocolPlus usage figures are first-party app data.

1. The New England Journal of Medicine (2023) — Jastreboff AM et al., Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial (doses 1/4/8/12 mg weekly; up to ~24% weight loss at 48 weeks). https://www.nejm.org/doi/full/10.1056/NEJMoa2301972 — retrieved 2026-06-15.
2. ClinicalTrials.gov — NCT04881760 (retatrutide Phase 2). https://clinicaltrials.gov/study/NCT04881760 — retrieved 2026-06-15.
3. ClinicalTrials.gov — NCT05929066 (TRIUMPH-1, retatrutide Phase 3; 4/9/12 mg). https://clinicaltrials.gov/study/NCT05929066 — retrieved 2026-06-15.
4. Eli Lilly (2026) — Retatrutide Phase 3 topline results (investigational, not approved). https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss — retrieved 2026-06-15.

About this guide. Written by Jordan Vance, peptide and biohacking researcher (placeholder, replace before publish), and medically reviewed by Dr. Maya Ellison, MD, biochemistry (placeholder, replace before publish), for the ProtocolPlus Research Team. This calculator and article are educational and not medical advice.